US FDA Warns of Deaths Tied To Gastric Balloons
Executive Summary
The agency doesn’t yet know the exact causes of the five deaths. This is the second safety alert on the obesity-treatment devices this year.
You may also be interested in...
EnteroMedics Inflates Neuromod-Obesity Offering With ReShape Balloon
The deal, worth $61m in cash and stock, will add ReShape's Dual Weight Loss Balloon to EnteroMedics' vBloc neurometabolic therapy and Gastric Vest System for the treatment of obesity.
Gastric Balloon-Makers Respond To US FDA Warning
Apollo Endosurgery and Reshape Medical are both defending their products’ safety in the wake of a US FDA letter warning of five deaths tied to the companies' intragastric balloon devices.
US FDA Warns Docs On Gastric Balloon Adverse Events
Gastric balloons from ReShape Medical and Apollo Endosurgery have been tied to pancreatitis and problems caused by over-inflation, the agency says.